Corebridge Financial Inc. decreased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 141,959 shares of the company's stock after selling 5,249 shares during the period. Corebridge Financial Inc.'s holdings in GE HealthCare Technologies were worth $11,098,000 as of its most recent filing with the SEC.
A number of other institutional investors have also made changes to their positions in the stock. Runnymede Capital Advisors Inc. acquired a new position in GE HealthCare Technologies during the 4th quarter worth $28,000. Continuum Advisory LLC lifted its position in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock worth $31,000 after purchasing an additional 168 shares during the last quarter. Bank of Jackson Hole Trust bought a new stake in GE HealthCare Technologies during the 4th quarter valued at approximately $32,000. OFI Invest Asset Management acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at approximately $34,000. Finally, Flagship Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the 4th quarter worth approximately $34,000. 82.06% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on GEHC shares. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and raised their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Citigroup upped their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $98.75.
Check Out Our Latest Stock Analysis on GEHC
GE HealthCare Technologies Price Performance
Shares of GEHC traded up $0.70 during mid-day trading on Monday, reaching $80.71. The company had a trading volume of 4,151,176 shares, compared to its average volume of 2,938,522. The company's 50-day moving average is $86.62 and its 200-day moving average is $85.81. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a market capitalization of $36.91 billion, a P/E ratio of 18.64, a P/E/G ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies's payout ratio is currently 3.23%.
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories

Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.